Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Endocrinología, Diabetes y Nutrición (English ed.) - Volume 64, Issue 7, August–September 2017, Pages 341-344

Emilio Ortega Martínez de Victoria,